A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag-Reference-Cited by-同舟云学术

A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag

Published:2003-02-01 Issue:3 Volume:170 Page:1416-1422
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Fitzgerald Julie C.,Gao Guang-Ping,Reyes-Sandoval Arturo,Pavlakis George N.,Xiang Zhi Q.,Wlazlo Anthony P.,Giles-Davis Wynetta,Wilson James M.,Ertl Hildegund C. J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

2. Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

3. A role for mucosal immunity in resistance to HIV infection

4. Simian Immunodeficiency Virus (SIV) gag DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection

5. Immune responses in HIV-exposed seronegatives: have they repelled the virus?

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses;Antiviral Research;2024-03

2. Razrabotka i harakteristika vektornoj sistemy na osnove adenovirusa obez'yan 25-go serotipa;Вестник Российского государственного медицинского университета;2023-02

3. Development and characterization of a vector system based on the simian adenovirus type 25;Bulletin of Russian State Medical University;2023-02

4. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy;Viruses;2022-12-06

5. Biological composition, efficacy, and primary efficacy endpoint of SARS-CoV-2 vaccines; a special communication;Journal of the Pakistan Medical Association;2022-08-16